Skip to main navigation Skip to search Skip to main content

PoC Stage 3 (Vasimmune Compound 1 (VIC-1) An Orally Available Immunomodulatory Polysaccharide for Alzheimer's disease therapy)

Project: Research

Project Details

StatusActive
Effective start/end date5/05/255/11/27

Collaborative partners

  • Queens University Belfast (lead)

Funding

  • Invest Northern Ireland: £249,716.60